| Jul 29 |
Biggest stock movers today: Crypto stocks, PBI, PHG, and more
|
| Jul 29 |
NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations
|
| Jul 29 |
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
|
| Jul 26 |
NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024
|
| Jul 5 |
NewAmsterdam Pharma: Cholesterol Drug Treatment With Catalysts In 1-Year Period
|
| Jul 5 |
NewAmsterdam Pharma files $400M mixed securities shelf
|
| May 29 |
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June
|
